Millennium Management
CGON icon

Millennium Management’s CG Oncology CGON Stock Holding History

Millennium Management’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Sell
20,000
-50,000
-71% -$2.83M ﹤0.01% 4164
2025
Q4 		$2.91M Buy
+70,000
New +$2.9M ﹤0.01% 3600

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management's CGON Position: Q1 2026 in Review

Millennium Management sold out of CG Oncology (CGON) in Q1 2026, closing a stake of 91,454 shares — an estimated $5.18M sold.

Millennium Management first reported a position in CGON in Q1 2024 and held it in 7 quarters. The position peaked at $25M in Q2 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Millennium Management reported no remaining CG Oncology position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 91,454 CG Oncology shares in Q1 2026, an estimated $5.18M.
  • Millennium Management first reported a position in CG Oncology in Q1 2024 and held it in 7 quarters.
  • Millennium Management's CG Oncology position peaked at $25M in Q2 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.